Medibio Limited
(ASX:MEB) CEO, Kris Knauer told the conference ‘Medibio has developed the first evidence based quantitative test for depression and mental health disorders, addressing the largest issue in healthcare today.'
Mr Knauer outlined three clearly defined markets Medibio functions in: Medical, corporate and consumer. These three markets create a total industry valued at $75 billion.
Mr Knauer observed that the company has a 5 year revenue target of $100 million annual revenue.
